10x Genomics (TXG) Net Cash Flow Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.29 Bn | 27.22 Bn | 1.98 Bn | -394.13% |
| 2 | Veeva Systems | 26.21 Bn | 19.65 Bn | 622.47 Mn | -420.04% |
| 3 | BrightSpring Health Services | 11.98 Bn | 11.10 Bn | 482.22 Mn | 9,394.16% |
| 4 | Healthequity | 7.59 Bn | 7.27 Bn | 228.15 Mn | 136.88% |
| 5 | Hinge Health | 4.34 Bn | 4.03 Bn | 154.23 Mn | -76.26% |
| 6 | Waystar Holding | 3.75 Bn | 3.59 Bn | 268.04 Mn | -131.26% |
| 7 | Doximity | 3.73 Bn | 2.98 Bn | 125.97 Mn | 248.05% |
| 8 | 10x Genomics | 3.04 Bn | 2.50 Bn | 106.18 Mn | -50.15% |
| 9 | Privia Health | 2.83 Bn | 2.46 Bn | 595.71 Mn | -175.74% |
| 10 | Omnicell | 2.01 Bn | 1.84 Bn | 140.36 Mn | 188.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.15% |
| Dec 31, 2025 | 176.57% |
| Sep 30, 2025 | 92.69% |
| Jun 30, 2025 | -15.62% |
| Mar 31, 2025 | 1,051.66% |
| Dec 31, 2024 | -221.03% |
| Sep 30, 2024 | 213.41% |
| Jun 30, 2024 | 370.42% |
| Mar 31, 2024 | -103.07% |
| Dec 31, 2023 | 407.79% |
| Sep 30, 2023 | 60.08% |
| Jun 30, 2023 | 76.68% |
| Mar 31, 2023 | 140.74% |
| Dec 31, 2022 | -11.91% |
| Sep 30, 2022 | -0.99% |
| Jun 30, 2022 | -903.58% |
| Mar 31, 2022 | -514.85% |
| Dec 31, 2021 | 91.08% |
| Sep 30, 2021 | -109.25% |
| Jun 30, 2021 | 116.82% |
| Mar 31, 2021 | -0.91% |
| Dec 31, 2020 | -14,549.29% |
| Sep 30, 2020 | 3.25% |
| Jun 30, 2020 | -184.28% |
| Mar 31, 2020 | -5,188.56% |
| Dec 31, 2019 | 94.50% |